腹腔镜胃癌D2根治术的可行性及其疗效观察

Feasibility and Efficacy of Laparoscopic D2 Radical Operation for Gastric Cancer

目的探讨腹腔镜胃癌D2根治术的可行性及临床疗效。方法 32例行腹腔镜胃癌D2根治手术患者作为研究观察对象,同期选择行胃癌开腹手术的30例患者作为对照组,分析两组患者临床资料,对比两组患者手术情况、恢复情况及并发症发生情况。结果对照组手术时间比观察组明显较短,差异显著,P<0.05;观察组术中出血量明显低于对照组,切口长度明显较小,差异均具有统计学意义,P<0.05;两组清除淋巴结数无明显差异,P>0.05;观察组住院时间比对照组明显缩短,差异具有显著性,P<0.05;观察组胃肠道功能恢复时间和首次进流质食物时间也比对照组有明显缩短,差异均具有显著性,P<0.05;观察组并发症发生率为9.38%,明显低于对照组20.00%,差异具有显著性,P<0.05;两组清除淋巴结总数差异无显著性,P>0.05;第一、二站淋巴结清扫数目及上切端距离组间比较差异均无显著性,P>0.05,观察组下切端距离较对照组明显缩短,差异显著,P<0.05。结论腹腔镜胃癌D2根治术能够有效治疗胃癌,操作安全、有效,创伤较小,近期疗效良好,值得临床推广应用。

Objective To observe the feasibility and the clinical efficacy of laparoscopic D2 radical operation for gastric cancer. Methods 32 gastric cancer patients treated with laparoscopic D2 radical operation were the observation group,and 30 gastric cancer patients treated with open operation were the control group,a retrospective analysis of clinical data of the 2 groups were conducted. Operation condition,recovery and complications of the 2 groups were compared. Results In the control group,the operation time was significantly shorter than that of the observation group,the difference was significant,P < 0. 05; the amount of bleeding of the observation group was significantly less than that of the control group,the length of the incision was smaller,the difference was statistically significant,P < 0. 05; there had no significant difference between the 2 groups in clearance of lymph node number,P > 0. 05; hospitalization time in the observation group was significantly shorter the control group,the difference was significant,P < 0. 05; gastrointestinal function recovery time and for the first time into the liquid food time in the observation group were significantly shorter compared with the control group,the difference was significant,P < 0. 05; complication rate of the observation group was 9. 38%,which was significantly lower than that of the control group 20%,the difference was significant,P <0. 05. Conclusion Laparoscopic D2 radical operation for gastric cancer is safe,effective,with less trauma and good short-term efficacy,It is worthy of clinical application.